{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:53:19Z","timestamp":1790455999408,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epidermolysis bullosa (EB) is a disabling and chronic genodermatosis characterized by mucocutaneous fragility with blister formation after minimal trauma. Severity ranges between very mild forms to extremely severe or lethal subtypes. Depending on disease subtypes, blisters may be localized also in larynx, bladder, esophagus, and most frequent disease complications are malnutrition, chronic anemia, osteoporosis, limb contracture and early development of squamous cell carcinomas. EB is classified into four major groups: EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB) and Kindler EB (KEB). No specific treatment is available; however, a multidisciplinary management is mandatory in order to treat the lesions, to prevent complication, and to give a psychological support to the patient and family members.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To report the experience on a therapeutic education plan of an Italian reference center for epidermolysis bullosa in the last 30\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In our study we included all patients with EB from  1990\u00a0to the present, dividing them into three age groups (&lt;\u20095\u00a0years,\u2009&gt;\u20095\u201312\u00a0years and\u2009&gt;\u200912\u201318\u00a0years). The therapeutic plan involved all multidisciplinary team members, since born until adolescence. The multidisciplinary team has been progressively established; the dermatologists act as patient case manager, in collaboration with the pediatrician, endocrinologist, dietician, dentist, plastic surgeon, digestive surgeon, geneticist, psychologist and a dedicated nurse. Other dedicated specialists are involved upon patient needs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two hundred fifteen patients have been recruited and followed in our hospital since 1990. One hundred forty patients (65%) are on follow-up, 27 patients (13%) died and only 11 (5%) were lost to follow-up. Our patients manifested the specific complications related to their EB subtype in keeping with the data reported in the literature. Eighteen (8%) patients affected with JEB severe died within the first year of life, 9 patients (5%) died for squamous cell carcinoma in adulthood and were affected with recessive DEB; only 1 patient died for squamous cell carcinoma at the age of 16.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>An adequate management of EB patients require a multidisciplinary approach with an educational plan to guarantee an appropriate treatment and to support and accompany patients and their families since birth along life. The dynamic educational plan adopted in our hospital showed good clinical and psychological outcome in our population, allowing adherence to treatment, reducing the frequency of complications and improving life expectancy and quality of life.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-022-01252-3","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T12:04:07Z","timestamp":1649765047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center"],"prefix":"10.1186","volume":"48","author":[{"given":"Chiara","family":"Retrosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Diociaiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"De Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Corbeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Giancristoforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Marchili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Luisa Ciofi degli","family":"Atti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8145-4797","authenticated-orcid":false,"given":"Maya","family":"El Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Raponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"issue":"4","key":"1252_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, Bauer J, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614\u201327.","journal-title":"Br J Dermatol"},{"key":"1252_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jaad.2003.09.026","volume":"50","author":"DT Devries","year":"2004","unstructured":"Devries DT, Johnson LB, Weiner M, Fine JD. Relative extent of skin involvement in inherited epidermolysis bullosa (EB): composite regional anatomic diagrams based on the findings of the National EB Registry, 1986 to 2002. J Am Acad Dermatol. 2004;50:572\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"1252_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jaad.2009.03.052","volume":"61","author":"JD Fine","year":"2009","unstructured":"Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61:367\u201384.","journal-title":"J Am Acad Dermatol"},{"key":"1252_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-9-76","volume":"9","author":"M El Hachem","year":"2014","unstructured":"El Hachem M, Zambruno G, Bourdon-Lanoy E, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis. 2014;9:76.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1252_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, Bauer J, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614\u201327.","journal-title":"Br J Dermatol"},{"key":"1252_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/bjd.14246","volume":"173","author":"H Defresne","year":"2015","unstructured":"Defresne H, Hadj-Rabia S, Taieb C, Bodemer C. Development and validation of an epydermolisis bullosa family\/parental burden score. Br J Dermatol. 2015;173:1357\u20138.","journal-title":"Br J Dermatol"},{"key":"1252_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1172-8-28","volume":"8","author":"H Dufresne","year":"2013","unstructured":"Dufresne H, Hadj-Rabia S, M\u00e9ni C, et al. Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis. 2013;8:28.","journal-title":"Orphanet J Rare Dis"},{"issue":"9\u201310","key":"1252_CR8","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/jocn.15209","volume":"29","author":"YH Wu","year":"2020","unstructured":"Wu YH, Sun FK, Lee PY. Family caregivers\u2019 lived experiences of caring for epidermolysis bullosa patients: A phenomenological study. J Clin Nurs. 2020;29(9\u201310):1552\u201360.","journal-title":"J Clin Nurs"},{"issue":"9","key":"1252_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2340\/00015555-3179","volume":"99","author":"P Mauritz","year":"2019","unstructured":"Mauritz P, Jonkman MF, Visser SS, et al. Impact of Painful Wound Care in Epidermolysis Bullosa During Childhood: An Interview Study with Adult Patients and Parents. Acta Derm Venereol. 2019;99(9):783\u20138.","journal-title":"Acta Derm Venereol"},{"key":"1252_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpeds.2007.06.039","volume":"152","author":"J-D Fine","year":"2008","unstructured":"Fine J-D, Johnson LB, Weiner M, Suchindran C. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr. 2008;152:276\u201380.","journal-title":"J Pediatr"},{"key":"1252_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2133.2012.10997.x","volume":"167","author":"WY Yuen","year":"2012","unstructured":"Yuen WY, Duipmans JC, Molenbuur B, et al. Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa. Br J Dermatol. 2012;167:374\u201382.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1252_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan A, Bruckner-Tuderman L, Chapple ILC, et al. Epidermolysis bullosa. Nat Rev Dis Primers. 2020;6(1):78.","journal-title":"Nat Rev Dis Primers"},{"key":"1252_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","volume":"60","author":"J-D Fine","year":"2009","unstructured":"Fine J-D, Johnson LB, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986\u20132006. J Am Acad Dermatol. 2009;60:203\u201311.","journal-title":"J Am Acad Dermatol"},{"issue":"22","key":"1252_CR14","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.3390\/ijms20225707","volume":"20","author":"AG Condorelli","year":"2019","unstructured":"Condorelli AG, Dellambra E, Logli E, et al. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives. Int J Mol Sci. 2019;20(22):5707.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1252_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/bjd.14104","volume":"174","author":"JE Mellerio","year":"2016","unstructured":"Mellerio JE, Robertson SJ, Bernardis C, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol. 2016;174(1):56\u201367.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1252_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-016-0489-9","volume":"11","author":"H Montaudi\u00e9","year":"2016","unstructured":"Montaudi\u00e9 H, Chiaverini C, Sbidian E, et al. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases. Orphanet J Rare Dis. 2016;11(1):117.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1252_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1525-1470.2002.00202.x","volume":"19","author":"T Ayman","year":"2002","unstructured":"Ayman T, Yerebakan O, Cift\u00e7ioglu MA, Alpsoy E. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma. Pediatr Dermatol. 2002;19(5):436\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"1252_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1365-4632.2009.03910.x","volume":"48","author":"KN Shivaswamy","year":"2009","unstructured":"Shivaswamy KN, Sumathy TK, Shyamprasad AL, Ranganathan C. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl. Int J Dermatol. 2009;48(7):731\u20133.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1252_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"JY Tang","year":"2021","unstructured":"Tang JY, Marinkovich MP, Lucas E, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021;16(1):175.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-022-01252-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T23:03:51Z","timestamp":1655852631000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-022-01252-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1186\/s13052-022-01252-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"30 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Committee- of Bambino Ges\u00f9 Children\u2019s Hospital agave the approval (the code number is: 2470_OPBG_2021), and informed consents for collecting and publishing anonymized personal data and for publishing clinical pictures were obtained from patient parents or from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication of the clinical pictures of the patients was obtained from their parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}